Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Psoriasis 1Congenital Abnormalities 1Autoimmune Diseases 1Arthritis, Psoriatic 1

Interventions

fludarabine phosphate 2Melphalan 2Etoposide 2Cyclophosphamide 2apremilast 1Whole-Body Irradiation 1Whole Genome Sequencing 1Valganciclovir 1Transplantation 1Therapeutics 1Tacrolimus 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Genetic Testing 1Gene Expression Profiling 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Cyclosporine 1Busulfan 1Antiviral Agents 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Congenital Abnormalities × apremilast × Clear all
NCT02775500 2025-01-28

Apremilast Pregnancy Exposure Registry

University of California, San Diego

Active not recruiting
233 enrolled

Congenital Abnormalities, Autoimmune Diseases, Psoriasis, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡